Evidence map›Paper›PMID 10734197›Full record

ArticleNucleic acids research2000

The RNA-binding domain of ribosomal protein L11 recognizes an rRNA tertiary structure stabilized by both thiostrepton and magnesium ion.

L B Blyn, L M Risen, R H Griffey, D E Draper

Open access · bronzeAbstract read
In one paragraph

Article in Nucleic acids research, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

L B BlynIbis Therapeutics, a Division of Isis Pharmaceuticals, 2292 Faraday Avenue, Carlsbad, CA 92008, USA. lblyn@isisph.com
L M Risen
R H Griffey
D E Draper
Ionis Pharmaceuticals (United States) · US

Funding

RIBOSOMAL RNA STRUCTURE AND INTERACTIONSR37GM029048 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI DRAPER, DAVID E. · 1996 to 2005
$2.1M
L11/23S RRNA INTERACTION--ANTIMICROBIAL DRUG DEVELOPMENTR43AI045210 · NIAID · ISIS PHARMACEUTICALS, INC. · PI BLYN, LAWRENCE B · 1999 to 1999
–
NIAID NIH HHS 1R43 AI45210-01NIGMS NIH HHS R37 GM029048NIGMS NIH HHS R37 GM29048
6 · The paper itself

Abstract

Antibiotics that inhibit ribosomal function may do so by one of several mechanisms, including the induction of incorrect RNA folding or prevention of protein and/or RNA conformational transitions. Thiostrepton, which binds to the 'GTPase center' of the large subunit, has been postulated to prevent conformational changes in either the L11 protein or rRNA to which it binds. Scintillation proximity assays designed to look at the binding of the L11 C-terminal RNA-binding domain to a 23S ribosomal RNA (rRNA) fragment, as well as the ability of thiostrepton to induce that binding, were used to demonstrate the role of Mg(2+), L11 and thio-strepton in the formation and maintenance of the rRNA fragment tertiary structure. Experiments using these assays with both an Escherichia coli rRNA fragment and a thermostable variant of that RNA show that Mg(2+), L11 and thiostrepton all induce the RNA to fold to an essentially identical tertiary structure.

Indexed as

Base SequenceMagnesiumNucleic Acid ConformationNucleic Acid DenaturationRibosomal ProteinsRNA, BacterialRNA-Binding ProteinsRNA, RibosomalThiostreptonMagnesiumribosomal protein L11Ribosomal ProteinsRNA, BacterialRNA-Binding ProteinsRNA, RibosomalThiostrepton

Identifiers

PMID10734197
PMCPMC102817
OpenAlexW1981706389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.